yahoo Press
Why UnitedHealth (UNH) Remains a Turnaround Bet Despite Policy and Cost Pressure
Images
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational. UnitedHealth Group Incorporated (NYSE:UNH) is one of the best stocks to buy according to Goldman Sachs’ Conviction List. Goldman added UnitedHealth to its U.S. Conviction List on May 1, alongside Interactive Brokers, while removing Abbott Laboratories and Keysight Technologies. The firm said its conviction lists highlight stocks it views favorably for investment, and UnitedHealth’s inclusion followed Goldman’s April 22 move to raise its price target to $435 from $400 while maintaining a Buy rating. Goldman cited the company’s first-quarter performance, higher full-year guidance, and a turnaround still in its early stages. The case is not frictionless because UnitedHealth is still working through medical cost pressures, scrutiny of its insurance practices, and a federal probe into its government-backed plans. Reuters reported on May 18 that the stock dipped after Berkshire Hathaway exited its stake, though analysts quoted by Reuters said the operational recovery still appeared to be moving in the right direction. On April 21, UnitedHealth reported Q1 2026 revenue of $111.7 billion, up 2% year-over-year, adjusted earnings of $7.23 per share, and raised its full-year adjusted earnings outlook to more than $18.25 per share. UnitedHealth Group Incorporated (NYSE:UNH) is a health care and well-being company operating through UnitedHealthcare and Optum, serving consumers, care providers, employers, governments, and health systems. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Disclosure: None. Follow Insider Monkey on Google News.
Comments
You must be logged in to comment.